Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Bio-Preserve International (BIPN)

No earlier versions found for this Subject.

Return to Bio-Preserve International (BIPN)

This sounds like a company with potential.

Bio-Preserve International (BIPN) 12/3 closing price 2 1/8.

The company has developed a proprietary organ preservation device. The applications for this device in organ transplantation and new drug developement could be unlimited.

-This device is ALREADY FDA APPROVED for kidney transplantation.
-BIPN's scientific advisory board includes some major names, including the co-discoverer of HIV (M.G. Sarngadharan, Ph.D.).
-The device is PC based and the company is based in Redmond, Washington (home of Microsoft)... not a bad spot for a new technology to take root.

-Finally, the company has only been public for a few months (merger announced 9/5/97 closed on 10/30/97). Undercovered and undiscovered.

I ordered a research packet on the company by calling...

1-800-457-5580 (press release also listed 1-800-457-5579 and 1-888-852-2212).

Am looking for any input on this company, its competition etc...

Good Luck